SEC Form 4 · accession 0001179110-18-005784
MEDICINES CO /DE · MDCO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Armin M Kessler
Director
Period of report
Jan 16, 2018
Accepted (ET)
Apr 18, 2018 · 5:51 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001113481
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2,F3 | Jan 16, 2018 | S | 10,000 | $27.37 | D | 140,993 | D | |
| Common StockF4,F3 | Apr 16, 2018 | S | 10,000 | $30.05 | D | 130,993 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The common stock sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 program adopted by the reporting person on August 30, 2017, which establishes certain dates for stock sales by the reporting person.
- F2The range of prices for the transactions reported on this line is between $27.07 and $27.81 per share. The price reported above reflects the weighted average sales price. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- F3Includes 3,000 shares of common stock held by the reporting person's spouse. The reporting person disclaims beneficial ownership of these securities except to the extent of his indirect pecuniary interest therein.
- F4The range of prices for the transactions reported on this line is between $29.82 and $30.50 per share. The price reported above reflects the weighted average sales price. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.